![]() |
|
![]() |
|
Clinical data | |
---|---|
Trade names | Sular |
AHFS/Drugs.com | Monograph |
MedlinePlus | a696009 |
Pregnancy category |
|
Routes of administration |
Oral |
ATC code | C08CA07 (WHO) |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 99% |
Biological half-life | 7-12 hours |
Identifiers | |
|
|
CAS Number |
63675-72-9 ![]() |
PubChem (CID) | 4499 |
IUPHAR/BPS | 2524 |
DrugBank |
DB00401 ![]() |
ChemSpider |
4343 ![]() |
UNII |
4I8HAB65SZ ![]() |
KEGG |
D00618 ![]() |
ChEBI |
CHEBI:7577 ![]() |
ChEMBL |
CHEMBL1726 ![]() |
ECHA InfoCard | 100.058.534 |
Chemical and physical data | |
Formula | C20H24N2O6 |
Molar mass | 388.414 g/mol |
![]() ![]() |
Nisoldipine (INN) is a calcium channel blocker of the dihydropyridine class. It sold in the United States under the proprietary name Sular. Nisoldipine has tropism for cardiac blood vessels.